Hassles with taking out the garbage: Aggravating aggresomes

被引:322
作者
Garcia-Mata, R [1 ]
Gao, YS [1 ]
Sztul, E [1 ]
机构
[1] Univ Alabama Med Sci, Dept Cell Biol, Birmingham, AL 35294 USA
关键词
aggregation; aggresome; autophagy; chaperones; degradation; intermediate filament; misfolding; neurodegeneration; proteasome;
D O I
10.1034/j.1600-0854.2002.30602.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Diverse human diseases ranging from amyloidosis to neurodegenerative diseases are now recognized as 'conformational diseases' caused by protein misfolding and protein aggregation. Misfolded and aggregated proteins are usually handled in the cell through chaperone-mediated refolding, or when that is impossible, destroyed by proteasomal degradation. Recent evidence suggests that cells might have evolved a third pathway that involves the sequestration of aggregated proteins into specialized 'holding stations' called aggresomes. The aggresomal pathway provides a mechanism by which aggregated proteins form particulate (similar to 200 nm) mini-aggregates that are transported on microtubules (MTs) towards the MT organizing center (MTOC) by a process mediated by the minus-end motor protein dynein. Once at the MTOC, the individual particles pack into a single, usually spherical aggresome (1-3 mum) that surrounds the MTOC. Aggresomes are dynamic: they recruit various chaperones and proteasomes, presumably to aid in the disposal of the aggregated proteins. In addition, the formation of an aggresome is likely to activate the autophagic clearance mechanism that terminates in lysosomal degradation. Hence, the aggresome pathway may provide a novel system to deliver aggregated proteins from the cytoplasm to lysosomes for degradation. Although it is clear that many pathological states correlate with the formation of aggresomes, their causal relationships remain hotly debated. Here, we describe the current state of our knowledge of the aggresome pathway and outline the open questions that provide the focus of current research.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 55 条
[1]   Ubiquitin and the control of protein fate in the secretory and endocytic pathways [J].
Bonifacino, JS ;
Weissman, AM .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :19-57
[2]   PRE-GOLGI DEGRADATION OF NEWLY SYNTHESIZED T-CELL ANTIGEN RECEPTOR CHAINS - INTRINSIC SENSITIVITY AND THE ROLE OF SUBUNIT ASSEMBLY [J].
BONIFACINO, JS ;
SUZUKI, CK ;
LIPPINCOTTSCHWARTZ, J ;
WEISSMAN, AM ;
KLAUSNER, RD .
JOURNAL OF CELL BIOLOGY, 1989, 109 (01) :73-83
[3]   Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 [J].
Bruijn, LI ;
Houseweart, MK ;
Kato, S ;
Anderson, KL ;
Anderson, SD ;
Ohama, E ;
Reaume, AG ;
Scott, RW ;
Cleveland, DW .
SCIENCE, 1998, 281 (5384) :1851-1854
[4]   MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE [J].
BUXBAUM, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :323-346
[5]  
COGNE M, 1992, BLOOD, V79, P2181
[6]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[7]   Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains [J].
Dul, JL ;
Davis, DP ;
Williamson, EK ;
Stevens, FJ ;
Argon, Y .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :705-715
[8]   Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS [J].
Durham, HD ;
Roy, J ;
Dong, L ;
Figlewicz, DA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05) :523-530
[9]   ER quality control: towards an understanding at the molecular level [J].
Ellgaard, L ;
Helenius, A .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (04) :431-437
[10]  
Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X